These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1302 related articles for article (PubMed ID: 16078324)

  • 21. New centromere autoantigens identified in systemic sclerosis using centromere protein microarrays.
    Song G; Hu C; Zhu H; Wang L; Zhang F; Li Y; Wu L
    J Rheumatol; 2013 Apr; 40(4):461-8. PubMed ID: 23418382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sjögren's syndrome in patients with the CREST variant of progressive systemic scleroderma.
    Drosos AA; Pennec YL; Elisaf M; Lamour A; Acritidis NC; Jouquan JR; Moutsopoulos HM; Youinou P
    J Rheumatol; 1991 Nov; 18(11):1685-8. PubMed ID: 1787489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticentromere antibody positive Sjögren's Syndrome: a retrospective descriptive analysis.
    Bournia VK; Diamanti KD; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Res Ther; 2010; 12(2):R47. PubMed ID: 20302639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
    Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
    Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison between anti-Th/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement.
    Mitri GM; Lucas M; Fertig N; Steen VD; Medsger TA
    Arthritis Rheum; 2003 Jan; 48(1):203-9. PubMed ID: 12528120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis.
    Cavazzana I; Ceribelli A; Taraborelli M; Fredi M; Norman G; Tincani A; Satoh M; Franceschini F
    J Rheumatol; 2011 Oct; 38(10):2180-5. PubMed ID: 21921093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The clinical spectrum of patients with anticentromere antibodies].
    Insua Vilariño S; de la Hera Martínez M; Rodríguez-Valverde V; Merino Pérez J; Alonso Valdivieso JL; Ruiz T
    Rev Clin Esp; 1993 Apr; 192(6):260-4. PubMed ID: 8497719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The frequency of sicca symptoms and Sjögren's syndrome in patients with systemic sclerosis.
    Kobak S; Oksel F; Aksu K; Kabasakal Y
    Int J Rheum Dis; 2013 Feb; 16(1):88-92. PubMed ID: 23441777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-centromere antibodies in a large cohort of systemic sclerosis patients: comparison between immunofluorescence, CENP-A and CENP-B ELISA.
    Mahler M; You D; Baron M; Taillefer SS; Hudson M; ; Fritzler MJ
    Clin Chim Acta; 2011 Oct; 412(21-22):1937-43. PubMed ID: 21756890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical correlates of CENP-A and CENP-B antibodies in a large cohort of patients with systemic sclerosis.
    Hudson M; Mahler M; Pope J; You D; Tatibouet S; Steele R; Baron M; ; Fritzler M
    J Rheumatol; 2012 Apr; 39(4):787-94. PubMed ID: 22467948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases.
    Yamamoto AM; Amoura Z; Johannet C; Jeronimo AL; Campos H; Koutouzov S; Piette JC; Bach JF
    Arthritis Rheum; 2000 Mar; 43(3):689-98. PubMed ID: 10728764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical course of patients with anti-RNP antibodies. A prospective study of 32 patients.
    Lundberg I; Hedfors E
    J Rheumatol; 1991 Oct; 18(10):1511-9. PubMed ID: 1765975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ro(SSA) and La(SSB) antibodies in the clinical spectrum of Sjögren's syndrome.
    Alexander EL; Hirsch TJ; Arnett FC; Provost TT; Stevens MB
    J Rheumatol; 1982; 9(2):239-46. PubMed ID: 7097683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
    Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T
    Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Primary biliary cirrhosis (PBC)-CREST overlap syndrome complicated with Sjögren's syndrome].
    Akiyama Y; Suzuki T; Tanaka M; Fujimaki T; Asaoka T; Kobayashi K; Ohno S; Imai F; Matuo H
    Ryumachi; 1997 Feb; 37(1):42-7. PubMed ID: 9128423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sjögren's syndrome with anticentromere antibodies.
    Caramaschi P; Biasi D; Carletto A; Manzo T; Randon M; Zeminian S; Bambara LM
    Rev Rhum Engl Ed; 1997 Dec; 64(12):785-8. PubMed ID: 9476266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients.
    Franceschini F; Cavazzana I; Generali D; Quinzanini M; Viardi L; Ghirardello A; Doria A; Cattaneo R
    J Rheumatol; 2002 Jul; 29(7):1393-7. PubMed ID: 12136894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases.
    Shovman O; Gilburd B; Zandman-Goddard G; Yehiely A; Langevitz P; Shoenfeld Y
    Autoimmunity; 2005 Feb; 38(1):105-9. PubMed ID: 15804711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antinuclear antibodies in primary biliary cirrhosis].
    Mzali S; Johanet C; Chrétien P; Abuaf N
    Gastroenterol Clin Biol; 1989; 13(8-9):690-5. PubMed ID: 2680726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
    Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL
    Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 66.